SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: PK who wrote (771)5/6/1998 12:32:00 PM
From: PAL  Read Replies (2) | Respond to of 2135
 
Peter Johnson, CEO of Agouron Pharmaceutical which has cancer drug on Phase II/III (much more ahead than ENMD) stated that this is not zero sum game, but there will be several drug companies with cancer fighting products in the market. Johnson said that under ideal condition, his drug could be in the market in 2000.